F Lobban1, A L Dodd2, D Dagnan3, P J Diggle4, M Griffiths2, B Hollingsworth5, D Knowles2, R Long2, S Mallinson6, R M Morriss7, R Parker2, A P Sawczuk2, S Jones2. 1. Spectrum Centre for Mental Health Research, Lancaster University, Lancaster, UK. Electronic address: f.lobban@lancaster.ac.uk. 2. Spectrum Centre for Mental Health Research, Lancaster University, Lancaster, UK. 3. Cumbria Partnership NHS Foundation Trust, UK. 4. Faculty of Medicine, Lancaster University, UK; Institution for Infection and Global Health, University of Liverpool, UK. 5. Division of Health Research, Lancaster University, Lancaster, UK. 6. Alberta Health Services, Toronto, Canada. 7. School of Medicine, University of Nottingham, UK.
Abstract
BACKGROUND: Relapse prevention interventions for Bipolar Disorder are effective but implementation in routine clinical services is poor. Web-based approaches offer a way to offer easily accessible access to evidence based interventions at low cost, and have been shown to be effective for other mood disorders. METHODS/ DESIGN: This protocol describes the development and feasibility testing of the ERPonline web-based intervention using a single blind randomised controlled trial. Data will include the extent to which the site was used, detailed feedback from users about their experiences of the site, reported benefits and costs to mental health and wellbeing of users, and costs and savings to health services. We will gain an estimate of the likely effect size of ERPonline on a range of important outcomes including mood, functioning, quality of life and recovery. We will explore potential mechanisms of change, giving us a greater understanding of the underlying processes of change, and consequently how the site could be made more effective. We will be able to determine rates of recruitment and retention, and identify what factors could improve these rates. DISCUSSION: The findings will be used to improve the site in accordance with user needs, and inform the design of a large scale evaluation of the clinical and cost effectiveness of ERPonline. They will further contribute to the growing evidence base for web-based interventions designed to support people with mental health problems.
RCT Entities:
BACKGROUND: Relapse prevention interventions for Bipolar Disorder are effective but implementation in routine clinical services is poor. Web-based approaches offer a way to offer easily accessible access to evidence based interventions at low cost, and have been shown to be effective for other mood disorders. METHODS/ DESIGN: This protocol describes the development and feasibility testing of the ERPonline web-based intervention using a single blind randomised controlled trial. Data will include the extent to which the site was used, detailed feedback from users about their experiences of the site, reported benefits and costs to mental health and wellbeing of users, and costs and savings to health services. We will gain an estimate of the likely effect size of ERPonline on a range of important outcomes including mood, functioning, quality of life and recovery. We will explore potential mechanisms of change, giving us a greater understanding of the underlying processes of change, and consequently how the site could be made more effective. We will be able to determine rates of recruitment and retention, and identify what factors could improve these rates. DISCUSSION: The findings will be used to improve the site in accordance with user needs, and inform the design of a large scale evaluation of the clinical and cost effectiveness of ERPonline. They will further contribute to the growing evidence base for web-based interventions designed to support people with mental health problems.
Authors: Erin E Michalak; Steven Jones; Fiona Lobban; Guillermo Perez Algorta; Steven J Barnes; Lesley Berk; Michael Berk; Rachelle Hole; Sara Lapsley; Victoria Maxwell; Roumen Milev; John McManamy; Greg Murray; Mauricio Tohen; Samson Tse; Manuel Sanchez de Carmona; Sheri L Johnson Journal: Int J Bipolar Disord Date: 2016-02-09
Authors: Fiona Lobban; Alyson L Dodd; Adam P Sawczuk; Ozgur Asar; Dave Dagnan; Peter J Diggle; Martin Griffiths; Mahsa Honary; Dawn Knowles; Rita Long; Richard Morriss; Rob Parker; Steven Jones Journal: J Med Internet Res Date: 2017-03-24 Impact factor: 5.428
Authors: Amy Hardy; Anna Wojdecka; Jonathan West; Ed Matthews; Christopher Golby; Thomas Ward; Natalie D Lopez; Daniel Freeman; Helen Waller; Elizabeth Kuipers; Paul Bebbington; David Fowler; Richard Emsley; Graham Dunn; Philippa Garety Journal: JMIR Ment Health Date: 2018-12-05
Authors: Maria Faurholt-Jepsen; Klaus Munkholm; Mads Frost; Jakob E Bardram; Lars Vedel Kessing Journal: BMC Psychiatry Date: 2016-01-15 Impact factor: 3.630
Authors: Fiona Lobban; Heather Robinson; Duncan Appelbe; Johanna Barraclough; Emma Bedson; Lizzi Collinge; Susanna Dodd; Sue Flowers; Mahsa Honary; Sonia Johnson; Ceu Mateus; Barbara Mezes; Valerie Minns; Elizabeth Murray; Andrew Walker; Paula Williamson; Catherine Wintermeyer; Steven Jones Journal: BMJ Open Date: 2017-07-18 Impact factor: 2.692